Radar Therapeutics

A glimpse into the future of genetic medicine. In tomorrows episode of "She Leads Biotech" we explore the transformative potential of genetic medicine with Sophia Lugo the CEO and Chairman of Radar Therapeutics. Founded just five months ago, Radar is revolutionizing the delivery of genetic therapies, with Sophia and her co-founder and CSO Eerik Kaseniit at the forefront of this groundbreaking innovation. Recently awarded the 2024 Biocam California Life Science Catalyst Award, she shares her exhilarating journey in an uncharted field and the unique challenges and triumphs that come with it. Sophia emphasizes the importance of passion in entrepreneurship, reminding us that if you don’t love the problem, you shouldn’t embark on the journey. #biotech #celltherapy #geneticmedicine #startup #sheleadsbiotech #WIB

🌟 We’re thrilled to share that Radar has been honored with the WACKER Biotech Discovery Award! 🎉 Healthcare innovation should be inclusive of all patients and backgrounds, and we’re proud to bring that vision to life every day. We look forward to collaborating with the WACKER team to propel our mission forward—delivering precisely expressed programmable genetic medicines for all. Join us at the California Life Sciences (CLS) Innovation Showcase on Dec. 10 to learn more about our work and meet our team! #GeneTherapy #LifeSciences #HealthcareInnovation #SyntheticBiology #EquitableHealthcare #CALifeSciences

Throwback to this incredibly fun interview with our founders, and Anna Rose Welch and Matthew Pillar from Business of Biotech!

Honored to be named one of 10 Life Science Catalyst Award Winners for 2024 by Biocom California. 🎉 The award recognizes the "most inspiring and innovative minds dedicated to advancing human health through research, discovery and entrepreneurship, with a commitment to DEI" under the age of 40. I'm proud to represent Radar Therapeutics and our team of world-class scientists that are truly pushing the boundaries of what is possible for targeted, safe, accessible genetic medicines. It's an honor to work alongside my co-founder and RADAR inventor Eerik Kaseniit on this journey. I was elated to be one of TWO MEXICANAS on the list! 🇲🇽 🇲🇽 I couldn't imagine someone more deserving than Ana Maria Moreno, a trusted mentor and CEO I've looked up to since starting the Radar journey! Shout out to fellow RNA-er David Weinberg as well, whose work the Radar team has admired since before our inception. Full list of winners here: https://bit.ly/3BLIGbt #LifeSciences #CatalystAwards #Innovation #RNA #Biotech

We’re thrilled to announce that our CEO and co-founder, Sophia Lugo, has been recognized as a recipient of the prestigious 2024 Biocom California Life Science Catalyst Award! 🎉 This honor celebrates rising leaders who are driving significant advancements in the life sciences across California, with Sophia recognized among an impressive list of founders, corporate leaders, and visionaries. This award reflects the collective dedication and hard work of the Radar Therapeutics team. Together, we’re harnessing the potential of ADAR-guided RNA editing to pioneer new treatments and transform genetic medicine. Sophia’s visionary leadership is driving Radar’s mission forward and setting new standards in the field. Thank you to Biocom California for this recognition, and congratulations to all the remarkable honorees shaping the future of the life sciences industry! 🚀 #Teamwork #Innovation #LifeSciences #CatalystAwards #Biocom

We’re thrilled to announce that our CEO and co-founder, Sophia Lugo, has been recognized as a recipient of the prestigious 2024 Biocom California Life Science Catalyst Award! 🎉 This honor celebrates rising leaders who are driving significant advancements in the life sciences across California, with Sophia recognized among an impressive list of founders, corporate leaders, and visionaries. This award reflects the collective dedication and hard work of the Radar Therapeutics team. Together, we’re harnessing the potential of ADAR-guided RNA editing to pioneer new treatments and transform genetic medicine. Sophia’s visionary leadership is driving Radar’s mission forward and setting new standards in the field. Thank you to Biocom California for this recognition, and congratulations to all the remarkable honorees shaping the future of the life sciences industry! 🚀 #Teamwork #Innovation #LifeSciences #CatalystAwards #Biocom

It was a privilege for Radar Therapeutics to be included among the “Groundbreakers - Five Companies Changing the Paradigm” at the Biotech Alchemy Life Sciences Summit in Philadelphia! Our CEO joined incredible leaders from Interius BioTherapeutics, iECURE, Inc., Latus Bio, Vittoria Biotherapeutics, Inc., and Code Biotherapeutics for an inspiring discussion on innovation in genetic medicine. We’re grateful for the opportunity to share our vision and connect with fellow innovators in the space. Here’s to pushing the boundaries of what’s possible in genetic medicine! 🚀 #BiotechAlchemy #Innovation #LifeSciences #GeneticMedicine

The future of RNA editing looks bright! Thanks for the shout-out BioPharma Dive

Team Radar is voting for Bakar BioEnginuity Hub Bakar Labs for the CLS Pantheon Awards! Bakar has served as an excellent launching ground for our company.

🌟 Thank you to everyone who joined us for our panel, "Missed Opportunities: The Cost of Ignoring Diversity in Biotech," at Biotech Week Boston! 🌟 We were honored to have such insightful perspectives from our incredible panelists José Trevejo, MD, PhD, Sophia Lugo, Carlos Bosques, and Jose Estabil. A special thank you to our fantastic moderator, Carolina Alarco, for guiding the conversation and making it an engaging discussion. The panel highlighted the immense value diversity brings to innovation and success in biotech, and we’re grateful to everyone who contributed to this important conversation. Thank you to Informa Connect and the Biotech Week Boston team (Louisa Maitland, Howard L. Choi) for providing the platform. Let’s continue working together to drive meaningful change in the life sciences industry! #LatinosInBio #BiotechWeekBoston #DiversityInBiotech #LifeSciences #Innovation